Skip to Main Content

Paper Details

The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Clin Cancer Res
41
2016
Author NameAffiliation
Julia E MaxsonClinical Research Division, Fred Hutchinson Cancer Research Center, Washington. Knight Cancer Institute, Oregon Health & Science University
Samuel B LutyKnight Cancer Institute, Oregon Health & Science University
Jason D MacManimanKnight Cancer Institute, Oregon Health & Science University
Jason GotlibStanford University School of Medicine/Stanford Cancer Institute
Samantha L SavageKnight Cancer Institute, Oregon Health & Science University
Melissa L AbelKnight Cancer Institute, Oregon Health & Science University
Christopher A EideKnight Cancer Institute, Oregon Health & Science University
Marc M LoriauxKnight Cancer Institute, Oregon Health & Science University
Emily A StevensClinical Research Division, Fred Hutchinson Cancer Research Center
Jeffrey W TynerKnight Cancer Institute, Oregon Health & Science University
  • 1 - 10

Datasets

Release 1.2